Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Progression-Free Survival (PFS). After: Measure: Percent of Patients who Experience Dose Limiting Toxicity (DLT) (Part 1) Measure: Number of Patients with 1 or More Adverse Events (AEs) Leading to Study Drug Discontinuations or Dose Modifications (Part 1) Measure: Progression-Free Survival (PFS) (Part 2).
Planned enrollment increased by 20 participants
Before: 60 participants (planned). After: 80 participants (planned).
Primary completion date changed
Before: Jul 2027. After: Sep 2027.